| Literature DB >> 35316543 |
Patrick Stafler1,2, Khaled Akel1, Yuliana Eshel3, Adi Shimoni3, Sylvia Grozovski2,4, Meir Mei-Zahav1,2, Hagit Levine1,2, Yulia Gendler5, Hannah Blau1,2, Dario Prais1,2.
Abstract
AIM: Videofluoroscopy swallow studies (VFSS) are gold standard to diagnose aspiration in children but require resources and radiation compared with clinical feeding evaluation (CFE). We evaluated their added value for diagnosis, feeding management and clinical status.Entities:
Keywords: chronic pulmonary aspiration; overt aspiration; silent aspiration; videofluoroscopic swallow study
Mesh:
Year: 2022 PMID: 35316543 PMCID: PMC9325498 DOI: 10.1111/apa.16338
Source DB: PubMed Journal: Acta Paediatr ISSN: 0803-5253 Impact factor: 4.056
FIGURE 1Purpose‐built adaptable chair, adjustable in a way that mimics the child's usual feeding position
Eight‐point penetration‐aspiration scale, designed for videofluoroscopy swallow studies and adapted for clinical assessment
| Category | Score | Description (radiological) | Description (clinical) |
|---|---|---|---|
| No penetration or aspiration | 1 | Contrast does not enter the airway | No aspiration |
| Penetration | 2 | Contrast enters the airway, remains above vocal folds, no residue | |
| 3 | Contrast remains above vocal folds, visible residue remains | ||
| 4 | Contrast contacts vocal folds, no residue | ||
| 5 | Contrast contacts vocal folds, visible residue remains | ||
| Aspiration | 6 | Contrast passes glottis, no sub‐glottic residue visible | Overt aspiration |
| 7 | Contrast passes glottis, visible sub‐glottic residue despite patient's response | ||
| 8 | Contrast passes glottis, visible sub‐glottic residue, absent patient response | Suspected silent aspiration |
FIGURE 2Flow diagram of examined patient population including results of clinical feeding evaluation and video‐fluoroscopic swallow studies
Aspiration status according to videofluoroscopy swallow study per patient, according to organ systems and medical diagnoses
| Category | Total | No aspiration | Overt aspiration | Silent aspiration | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % | % |
| % | % |
| % | % | |
| Demographics | |||||||||||
| Age ≤1 | 22 | 20% | 11 | 16% | 50% | 1 | 11% | 5% | 10 | 27% | 45% |
| Age >1 | 91 | 80% | 56 | 84% | 61% | 8 | 89% | 9% | 27 | 73% | 30% |
| Male | 67 | 61% | 43 | 64% | 63% | 6 | 67% | 10% | 18 | 49% | 27% |
| Female | 46 | 39% | 24 | 36% | 53% | 3 | 33% | 6% | 19 | 51% | 41% |
| Organ system | |||||||||||
| Neurology | 68 | 68% | 32 | 48% | 47% | 5 | 56% | 7% | 31 | 84% | 46% |
| GI | 73 | 64% | 41 | 61% | 56% | 7 | 78% | 9% | 25 | 68% | 35% |
| Cardiopulmonary | 98 | 87% | 55 | 82% | 56% | 7 | 78% | 7% | 36 | 97% | 37% |
| Genetic | 36 | 32% | 19 | 28% | 53% | 1 | 11% | 3% | 16 | 43% | 44% |
| Structural | 18 | 16% | 15 | 22% | 83% | 0 | 0% | 0% | 3 | 8% | 17% |
| Medical diagnoses | |||||||||||
| Down's Syndrome | 14 | 12% | 7 | 10% | 50% | 1 | 11% | 7% | 6 | 16% | 43% |
| CP | 21 | 19% | 6 | 9% | 29% | 4 | 44% | 19% | 11 | 30% | 52% |
| Dev delay | 37 | 32% | 18 | 26% | 49% | 5 | 56% | 13% | 14 | 37% | 38% |
| Congenital heart ds | 42 | 37% | 24 | 15% | 57% | 3 | 33% | 7% | 15 | 41% | 36% |
| Preterm <37 weeks | 16 | 14% | 10 | 69% | 63% | 1 | 11% | 6% | 5 | 14% | 31% |
| Aspiration lung ds | 87 | 78% | 46 | 3% | 53% | 6 | 67% | 7% | 35 | 95% | 40% |
| BPD | 3 | 3% | 2 | 67% | 0 | 0% | 0% | 1 | 3% | 33% | |
Legend: a indicates percentages of categories for the entire group, not mutually exclusive. b indicates the percentage of categories (demographics/organ systems/medical diagnoses) represented in each of the three aspiration modes (no aspiration, overt aspiration and silent aspiration); for example out of 67 children that did not aspirate, 32 (48%) had neurological abnormalities, 41 (61%) GI abnormalities, etc. c indicates percentage of aspiration status relative to category; for example 32 out of 68 (47%) of all children with neurological problems did not aspirate, 5 (7%) and 31 (46%) showed overt and silent aspirations respectively.
Abbreviations: BPD, broncho‐pulmonary dysplasia; CP, cerebral palsy; Dev delay, developmental delay; GI, gastro‐intestinal.
Percentage of total group.
Percentage of category (demographics/organ systems/medical diagnoses) relative to aspiration status.
Percentage of aspiration status (no aspiration, overt aspiration and silent aspiration) relative to category.
FIGURE 3Aspiration status—no aspirations, overt or silent aspirations—according to food texture trialled, as identified on videofluoroscopy swallow study. N = 113
Logistic regression model describing the relationship between medical diagnoses and the presence of aspiration (combined overt and silent), according to VFSS
| Medical diagnoses | OR | 95% CI |
| AOR | 95% CI |
|
|---|---|---|---|---|---|---|
| CP | 9.8 | 2.2–42.8 | 0.002 | 10.21 | 2.27–45.95 | 0.002 |
| Aspiration lung disease | 3.2 | 1.4–12.4 | 0.009 | 3.3 | 1.82–12.7 | 0.008 |
| Developmental delay | 1.8 | 0.6–4.9 | 0.3 | 1.64 | 0.58–4.65 | 0.351 |
| Congenital heart disease | 1.7 | 0.5–5.7 | 0.4 | 1.61 | 0.47–5.53 | 0.444 |
| Preterm <37 weeks | 0.2 | 0.04–1.5 | 0.1 | 0.24 | 0.04–1.41 | 0.115 |
| Down's Syndrome | 0.8 | 0.2–3.9 | 0.7 | 0.77 | 0.15–3.88 | 0.755 |
| BPD | 0.6 | 0.02–14.6 | 0.7 | 0.59 | 0.23–14.9 | 0.741 |
Abbreviations: AOR, age adjusted odds ratio; BPD, broncho‐pulmonary dysplasia; CI, confidence interval; CP, cerebral palsy; OR, odds ratio.
Significant at p < 0.05.
Clinical outcomes 1 year pre vs. 1 year post VFSS, per patient (n = 113). Values displayed as mean (SD)
| Outcome | Year pre VFSS | Year post VFSS |
|
|---|---|---|---|
| Total no of admissions | 3.42 (3.42) | 2.33 (2.59) | <0.001 |
| No of urgent admissions | 2.05 (2.1) | 1.12 (1.05) | <0.001 |
| Total days of admission | 20.92 (13.66) | 9.78 (7.54) | <0.001 |
| Respiratory admissions | 1.54 (0.87) | 0.97 (0.66) | 0.04 |
| Intensive care admissions | 0.28 (0.18) | 0.19 (0.09) | N/S |
| Total community visits | 14.64 (9.65) | 16.49 (10.46) | N/S |
| Respiratory community visits | 2.44 (2.27) | 2.3 (2.02) | N/S |
| Emergency room visits | 3.69 (3.24) | 3.12 (2.86) | N/S |
| Antibiotic courses | 2.88 (2.56) | 1.8 (0.89) | <0.001 |